SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. ____ )*

GeoVax Labs, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

373678 309

(CUSIP Number)

September 29, 2020

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

	Rule 13d-1(b)
ü	Rule 13d-1(c)
	Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).

CUSIP No. 373678 309                                             13G                                                  Page 2 of 6 Pages

1	NAME OF REPORTING PERSON Cavalry Fund I Management LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)   ¨ (b)   ¨
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
	NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 242,625(1)
		6	SHARED VOTING POWER (see Item 5 below) 0
		7	SOLE DISPOSITIVE POWER 242,625(1)
		8	SHARED DISPOSITIVE POWER (see Item 5 below) 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 242,625(1)
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES þ (2)
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.8%
12	TYPE OF REPORTING PERSON OO

CUSIP No. 373678 309                                             13G                                                  Page 3 of 6 Pages

1	NAME OF REPORTING PERSON Thomas Walsh
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)   ¨ (b)   ¨
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION United States
	NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 242,625(1)
		6	SHARED VOTING POWER (see Item 5 below) 0
		7	SOLE DISPOSITIVE POWER 242,625(1)
		8	SHARED DISPOSITIVE POWER (see Item 5 below) 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 242,625(1)
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES þ (2)
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.8%
12	TYPE OF REPORTING PERSON IN

(1)

Represents 121,312 shares of common stock held by Cavalry Fund I LP and 121,313 shares of common stock held by Cavalry Special Ops Fund LLC. Cavalry Fund I Management LLC is the general partner of Cavalry Fund I LP and Cavalry Special Ops Fund LLC. Thomas Walsh is the Manager of Cavalry Fund I Management LLC. As such, Cavalry Fund I Management LLC and Mr. Walsh may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) 242,625 shares of Common Stock. To the extent Mr. Walsh is deemed to beneficially own such shares, Mr. Walsh disclaims beneficial ownership of these securities for all other purposes.

(2)

Cavalry Fund I LP and Cavalry Special Ops Fund LLC each own 215,035 shares of common stock issuable upon the exercise of certain pre-funded warrants and warrants, which are currently not exercisable due to a beneficial ownership limitation of 4.99% of the Company’s issued and outstanding common stock.

CUSIP No. 373678 309                                             13G                                                  Page 4 of 6 Pages

Item 1(a).	Name of Issuer
	GeoVax Labs, Inc. (“Issuer”)
Item 1(b).	Address of the Issuer’s Principal Executive Offices
	1900 Lake Park Drive, Suite 380, Smyrna, Georgia 30080
Item 2(a).	Names of Persons Filing
	This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

(i)	Cavalry Fund I Management LLC
(ii)	Thomas Walsh

Item 2(b).	Address of the Principal Business Office, or if none, Residence:
	The address for each Reporting Person is 61 Kinderkamack Road, Woodcliff Lake, NJ 07677.
Item 2(c).	Citizenship

Cavalry Fund I Management LLC is a limited liability company formed under the laws of Delaware.

Thomas Walsh is a citizen of the United States.

Item 2(d).	Title of Class of Securities
	Common Stock, $0.001 par value (“Common Stock”)
Item 2(e).	CUSIP Number
	373678 309

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

(a)  Broker or Dealer registered under Section 15 of the Exchange Act.

(b) Bank as defined in Section 3(a)(b) or the Exchange Act.

(c) Insurance company as defined in Section 3(a)(19) of the Exchange Act.

(d) Investment company registered under Section 8 of the Investment Company Act.

(e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e).

(f)  An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f).

(g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g).

(h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.

(i) A Church Plan that is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act.

CUSIP No. 373678 309                                             13G                                                  Page 5 of 6 Pages

(j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j).

Not applicable

Item 4.	Ownership
	The responses to Items 5-11 of the cover pages of this Schedule 13G are incorporated herein by reference.
	On June 26, 2020, Cavalry Fund I LP and Cavalry Special Ops Fund LLC were issued a 5% Original Issue Discount Senior Secured Convertible Debenture, which was mandatorily converted into common units and common pre-funded units upon the consummation of an underwritten public offering on September 29, 2020 (the “Offering”). Additionally, Cavalry Fund I LP and Cavalry Special Ops Fund LLC each purchased 32,500 common units in the Offering, consisting of 32,500 shares of common stock and 32,500 warrants to purchase common stock in the Offering.

Item 5.	Ownership of Five Percent or Less of a Class
	Not Applicable
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not Applicable

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
	Not Applicable
Item 8.	Identification and Classification of Members of the Group
	Not Applicable
Item 9.	Notice of Dissolution of Group
	Not Applicable
Item 10.	Certification
	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

CUSIP No. 373678 309                                             13G                                                  Page 6 of 6 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	Cavalry Fund I Management LLC
Date: October 20, 2020	Thomas Walsh, as Manager of Cavalry Fund I Management LLC
	By:	/s/ Thomas Walsh
		Name: Thomas Walsh
		Title: Manager
Date: October 20, 2020
	By:	/s/ Thomas Walsh
		Thomas Walsh